Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Visco, C; Tzankov, A; Xu Monette, Zy; Miranda, Rn; Tai, Yc; Li, Y; Liu, Wm; D'Amore, Es; Li, Y; Montes Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Wang, Hy; Dunphy, Ch; O' Neill, S; Hsi, Ed; Zhao, Xf; Choi, Ww; Zhao, X; van Krieken, Jh; Huang, Q; Ai, W; Ponzoni, Maurilio; Ferreri, Aj; Kahl, Bs; Winter, Jn; Go, Rs; Dirnhofer, S; Piris, Ma; Møller, Mb; Wu, L; Medeiros, Lj; Young, K. H.